Julia Humbarger, | |
12 Austin St Unit 2, Charlestown, MA 02129-3501 | |
(316) 299-9908 | |
Not Available |
Full Name | Julia Humbarger |
---|---|
Gender | Female |
Speciality | Marriage & Family Therapist |
Location | 12 Austin St Unit 2, Charlestown, Massachusetts |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1255748356 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
106H00000X | Marriage & Family Therapist | IMT 1651 (Florida) | Primary |
Mailing Address | Practice Location Address |
---|---|
Julia Humbarger, 12 Austin St Unit 2, Charlestown, MA 02129-3501 Ph: (316) 299-9908 | Julia Humbarger, 12 Austin St Unit 2, Charlestown, MA 02129-3501 Ph: (316) 299-9908 |
News Archive
New research shows that egg cholesterol does not impact the harmful, most atherogenic, LDL-cholesterol particles in blood, according to a new study published in the June issue of Metabolism.
To know how many proteins assemble together at the nanoscale is fundamental for understanding protein function. Sometimes, proteins must be in an "oligomeric" state to be functional, although "oligomerization" of certain proteins can also lead to diseases. The ability to determine protein stoichiometry and monitor changes in the balance between monomeric, dimeric and multi-meric proteins can allow scientists to see the differences between a properly functioning cell and a diseased cell. Therefore, there is a great interest in being able to count proteins and determine their stoichiometry.
Scientists with the Virginia Tech Carilion Research Institute say a gene involved in the body's circadian rhythms is a potential target for therapies to help patients with a deadly form of brain cancer known as glioblastoma.
For the first time, Fox Chase Cancer Center researchers have demonstrated the ability to extract RNA from formalin-fixed, paraffin-embedded tissue samples archived for up to five years. What's more, the technology used retrieves high-quality samples, allowing researchers to identify cancer-related genetic changes. Accepted as a "late-breaking" abstract, the research was presented today at the 95th Annual Meeting of the American Association for Cancer Research by Renata Coudry, M.D., a research pathologist at Fox Chase Cancer Center.
› Verified 2 days ago